Top cited articles

Acceptance rate

28%

Time to first decision with review

31 days*

Acceptance to publication

14 days*

Impact Factor

5.806

Citescore

7.1

Citescore rank

12/60

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Lopes, Maria Isabel; Bonjorno, Leticia P.; Giannini, Marcela C.; et al
10.1136/rmdopen-2020-001455

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Sattui, Sebastian Eduardo; Liew, Jean W.; Kennedy, Kevin; et al
10.1136/rmdopen-2021-001814

Glucocorticoids in rheumatoid arthritis: current status and future studies
Hua, Charlotte; Buttgereit, Frank; Combe, Bernard
10.1136/rmdopen-2017-000536

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
Lopez-Medina, Clementina; Molto, Anna; Sieper, Joachim; et al
10.1136/rmdopen-2020-001450

Reactive arthritis after COVID-19 infection
Ono, Keisuke; Kishimoto, Mitsumasa; Shimasaki, Teppei; et al
10.1136/rmdopen-2020-001350

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
Hasseli, Rebecca; Mueller-Ladner, Ulf; Hoyer, Bimba F.; et al
10.1136/rmdopen-2020-001464

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
Nishina, Naoshi; Sato, Shinji; Masui, Kenichi; et al
10.1136/rmdopen-2020-001202

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
Lopes Marques, Claudia Diniz; Kakehasi, Adriana Maria; Pinheiro, Marcelo Medeiros; et al
10.1136/rmdopen-2020-001461

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Cohen, Stanley B.; Tanaka, Yoshiya; Mariette, Xavier; et al
10.1136/rmdopen-2020-001395

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis
Ruyssen-Witrand, Adeline; Perry, Richard; Watkins, Clare; et al
10.1136/rmdopen-2019-001117

Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alunno, Alessia; Carubbi, Francesco; Rodriguez-Carrio, Javier
10.1136/rmdopen-2020-001295

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD
Hasseli, Rebecca; Mueller-Ladner, Ulf; Schmeiser, Tim; et al
10.1136/rmdopen-2020-001332

Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective
Pons-Estel, Guillermo J.; Francisco Ugarte-Gil, Manuel; Harvey, Guillermina B.; et al
10.1136/rmdopen-2019-001097

Probability-based algorithm using ultrasound and additional tests for suspected GCA in a fast-track clinic
Sebastian, Alwin; Tomelleri, Alessandro; Kayani, Abdul; et al
10.1136/rmdopen-2020-001297

Evidences for a protective role of vitamin D in COVID-19
Cutolo, Maurizio; Paolino, Sabrina; Smith, Vanessa
10.1136/rmdopen-2020-001454

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment
Van der Elst, Kristien; Verschueren, Patrick; De Cock, Diederik; et al
10.1136/rmdopen-2019-001146

DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability
Verstappen, M.; van Mulligen, E.; de Jong, P. H. P.; et al
10.1136/rmdopen-2020-001220

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
Roodenrijs, Nadia M. T.; Hamar, Attila; Kedves, Melinda; et al
10.1136/rmdopen-2020-001512

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
Ducourau, Emilie; Rispens, Theo; Samain, Marine; et al
10.1136/rmdopen-2019-001047

Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany
Sengler, Claudia; Eulert, Sascha; Minden, Kirsten; et al
10.1136/rmdopen-2021-001687